Format

Send to

Choose Destination
Arch Dis Child. 2009 Mar;94(3):224-6. doi: 10.1136/adc.2007.125195. Epub 2008 Jul 23.

Henoch-Schönlein purpura and meningococcal B vaccination.

Author information

1
Meningococcal Vaccine Strategy, Ministry of Health, Wellington, New Zealand.

Abstract

The risk of Henoch-Schönlein purpura (HSP) following vaccination with a group B meningococcal vaccine was assessed through active hospital safety monitoring. There was no increase in the relative incidence of HSP within 30 days after vaccination nor recurrence in HSP cases who received one or more further vaccine doses (re-challenge).

PMID:
18650242
DOI:
10.1136/adc.2007.125195
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center